Brilinta Tablets and Insulin lispro Subcutaneous
Determining the interaction of Brilinta Tablets and Insulin lispro Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ticagrelor
Brand name: Brilinta
Synonyms: Brilinta
Generic Name: insulin lispro
Brand name: Admelog, Humalog, HumaLOG Pen, HumaLOG KwikPen, HumaLOG Cartridge, HumaLOG Junior KwikPen, Admelog SoloStar, Humalog
Synonyms: Insulin lispro, Insulin Lispro
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brilinta Tablets-Insulin NPH
- Brilinta Tablets-Insulin NPH (InnoLets, Pens, and PenFill Cartridges)
- Brilinta Tablets-Insulin NPH (Vials)
- Brilinta Tablets-Insulin NPH and Insulin Regular
- Brilinta Tablets-Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills)
- Brilinta Tablets-Insulin NPH and Insulin Regular (Vials)
- Insulin lispro Subcutaneous-Brimonidine
- Insulin lispro Subcutaneous-Brimonidine and brinzolamide ophthalmic
- Insulin lispro Subcutaneous-Brimonidine and Timolol
- Insulin lispro Subcutaneous-Brimonidine and timolol ophthalmic
- Insulin lispro Subcutaneous-Brimonidine ophthalmic
- Insulin lispro Subcutaneous-Brimonidine Tartrate eent